Recursion: CDK7 Inhibitor Differentiation Is Initially Paying Off
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.
Enzymes are the engines of life − machine learning tools could help scientists design new ones to tackle disease and climate change
Enzymes significantly speed up the chemical reactions that keep you alive. Researchers are using AI to create new ones to tackle modern challenges.
The evolution of evolution itself: How evolution got so good at evolving
The field of evolution examines how organisms adapt to their environments over generations, but what about the evolution of ...
EDN13h
Tracking preregulator boosts efficiency of PWM power DAC
Implementing another power DAC with an LM317 regulator into a PWM topology but this one adds a preregulator so it can run ...